$2.580
-0.059 (-2.27%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ATOS por análisis de gráficos similares
Alphio's ATOS stock price prediction model matches the current Atossa Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.54 (-1.45%). The 1-week path is $2.49 (-3.49%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Atossa Therapeutics Inc?
Atossa Therapeutics Inc is a good buy right now due to its current price of $2.58, which is significantly lower than the analyst price target of $12, indicating a potential upside of 366%. Additionally, the stock has shown a positive trend with a 20-day change of +24.64%, suggesting a recovery momentum. However, the main risk is the ongoing losses, with a net income of -$8,491,000 reported for Q2 2026, which could impact future financing and investor confidence.
ATOS cerró en $2.58 el Friday, tras bajar -2.27%
Atossa Therapeutics Inc (ATOS) last closed at $2.58, losing -2.27%. These facts feed the 1-day and 1-week ATOS price prediction above.
Consenso de analistas
Atossa Therapeutics Inc (ATOS): 1 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Atossa Therapeutics Inc (ATOS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ATOS, ordenadas por similitud.
Análisis de estacionalidad de ATOS
Historically the probability of a positive August return for ATOS is 34.92%. October offers the highest probability of a positive month at 78.26%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ATOS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $0.67 | $0.78 | $0.92 | -69.68% |
| Sep 2026 | $0.76 | $0.89 | $1.08 | -65.45% |
| Oct 2026 | $0.77 | $0.82 | $0.84 | -68.24% |
| Nov 2026 | $0.93 | $1.02 | $1.03 | -60.60% |
| Dec 2026 | $0.77 | $0.88 | $0.99 | -65.93% |
En 2026, se proyecta que Atossa Therapeutics Inc (ATOS) oscile entre $0.67 y $1.08.
Previsión mensual de Atossa Therapeutics Inc para 2026
En Aug de 2026, se proyecta que Atossa Therapeutics Inc promedie $0.78, con un mínimo de $0.67 y un máximo de $0.92.
En Sep de 2026, se proyecta que Atossa Therapeutics Inc promedie $0.89, con un mínimo de $0.76 y un máximo de $1.08.
En Oct de 2026, se proyecta que Atossa Therapeutics Inc promedie $0.82, con un mínimo de $0.77 y un máximo de $0.84.
En Nov de 2026, se proyecta que Atossa Therapeutics Inc promedie $1.02, con un mínimo de $0.93 y un máximo de $1.03.
En Dec de 2026, se proyecta que Atossa Therapeutics Inc promedie $0.88, con un mínimo de $0.77 y un máximo de $0.99.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.